Search - tctmd.com

Displaying 341 - 360 of 399

Sort: Relevancy | Date

Podcast TCTMD Talking Points

Episode 25: RESPECT - Final Long-term Outcomes of PFO Closure for Cryptogenic Stroke

July 12, 2017

Presentation

CLOSE: Closure of PFO, Oral Anticoagulants, or Antiplatelet Therapy to Prevent Stroke Recurrence

May 24, 2017

Presentation

PFO Closure in the Gore REDUCE Clinical Trial

May 24, 2017

News Daily News

Two New Trials Buoy Outlook for PFO Closure in Patients With Cryptogenic Stroke

Todd Neale

May 24, 2017

Presentation ECHO 2017

Guidelines: Assessment of ASD and PFO and Evaluation of a Cardiac Source of Embolism

Presenter: Michael H. Picard

March 31, 2017

News Daily News

NeuroARC Proposes New Standards for Assessing Neurologic Damage in CV Clinical Trials

Caitlin E. Cox

February 07, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular News and Features for 2016

Shelley Wood

December 29, 2016

News Opinion Editor's Corner

TCTMD 年十大热门新闻、博客和焦点

Shelley Wood

December 29, 2016

PFO and Migraine? New Study Zeros in on Atrial Septal Aneurysms

News Daily News

¿FOP y Migrañas? Un Nuevo Estudio se Centra en los Aneurismas del Tabique Interauricular

Shelley Wood

December 08, 2016

News Daily News

PFO 和偏头痛？新研究关注房间隔动脉瘤

Shelley Wood

December 08, 2016

News Daily News

PFO and Migraine? New Study Zeros in on Atrial Septal Aneurysms

Shelley Wood

December 08, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2016

Shelley Wood

November 30, 2016

Presentation TCT 2016

Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do?

Presenter: Eustaquio Maria Onorato, Richard Smalling, Robert J. Sommer

November 01, 2016

Presentation TCT 2016

The REDUCE Trial: Will It Be Positive and What Will We Learn?

Presenter: Eustaquio Maria Onorato, Richard Smalling, John F. Rhodes

November 01, 2016

Presentation TCT 2016

What Should Be the Next Series of Clinical Trials in PFO Closure?

Presenter: Eustaquio Maria Onorato, Richard Smalling, John D. Carroll

November 01, 2016

Presentation TCT 2016

The Neurologist as the Gatekeeper of PFO Closure in the US: What is Cryptogenic Stroke and When Do Neurologists Think PFO Closure Is Needed?

Presenter: Eustaquio Maria Onorato, Richard Smalling, David E. Thaler

November 01, 2016

Presentation TCT 2016

Anticipating FDA approval of the Amplatzer PFO Occluder: Indications, Rational Dispersion of Technology, and Post-Approval Studies

Presenter: Eustaquio Maria Onorato, Richard Smalling

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: RESPECT Final Long-term Outcomes

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

Building a Successful PFO Closure Program

Presenter: John D. Carroll, Christian Spies

November 01, 2016

Presentation TCT 2016

Available Devices/Techniques for Closure of PFO

Presenter: John D. Carroll, Christian Spies, Michael J. Mullen

November 01, 2016

Advertisement

Episode 25: RESPECT - Final Long-term Outcomes of PFO Closure for Cryptogenic Stroke

CLOSE: Closure of PFO, Oral Anticoagulants, or Antiplatelet Therapy to Prevent Stroke Recurrence

PFO Closure in the Gore REDUCE Clinical Trial

Two New Trials Buoy Outlook for PFO Closure in Patients With Cryptogenic Stroke

Guidelines: Assessment of ASD and PFO and Evaluation of a Cardiac Source of Embolism

NeuroARC Proposes New Standards for Assessing Neurologic Damage in CV Clinical Trials

TCTMD’s Top 10 Most Popular News and Features for 2016

TCTMD 年十大热门新闻、博客和焦点

¿FOP y Migrañas? Un Nuevo Estudio se Centra en los Aneurismas del Tabique Interauricular

PFO 和偏头痛？新研究关注房间隔动脉瘤

PFO and Migraine? New Study Zeros in on Atrial Septal Aneurysms

TCTMD’s Top 10 Most Popular Stories for November 2016

Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do?

The REDUCE Trial: Will It Be Positive and What Will We Learn?

What Should Be the Next Series of Clinical Trials in PFO Closure?

The Neurologist as the Gatekeeper of PFO Closure in the US: What is Cryptogenic Stroke and When Do Neurologists Think PFO Closure Is Needed?

Anticipating FDA approval of the Amplatzer PFO Occluder: Indications, Rational Dispersion of Technology, and Post-Approval Studies

Highlights (and my Interpretations) From: RESPECT Final Long-term Outcomes

Building a Successful PFO Closure Program

Available Devices/Techniques for Closure of PFO

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content